Opendata, web and dolomites

FRINGE SIGNED

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FRINGE project word cloud

Explore the words cloud of the FRINGE project. It provides you a very rough idea of what is the project "FRINGE" about.

modality    join    photomedical    light    concomitant    therapeutic    combine    team    incoming    photobiologists    photosensitisers    physicists    survival    renowned    oncologists    combination    curative    world    breakthrough    confirmed    centres    tuned    act    interaction    metal    radio    death    experimental    chemical    agent    disciplines    theranostic    ambient    neutron    contain    medical    genuinely    designed    blood    foundations    imaging    accumulate    vaccine    excitation    advantages    quantum    magnetic    heart    barrier    generate    forces    gadolinium    rates    preferentially    lying    fringe    therapies    transfer    mutagenic    chemists    mainly    pss    sufficient    reactive    insufficient    therapy    lack    contrast    beam    scientific    cells    cancers    aggressive    brain    limited    occult    externally    gd    cell    photochemists    species    tumour    resonance    kill    energy    fluorescence    metastasis    oxygen    synthetic    proof    lay    activated    neutrons    experts    suffer    exactly    emission    eliminate    ps    specificity    marginal    treat    difficult    radiation    compromised    immunogenic    interdisciplinary    deep    agents    penetration    nuclear    tissue    tumours    cancer    hybrid    electron    causing   

Project "FRINGE" data sheet

The following table provides information about the project.

Coordinator
OSLO UNIVERSITETSSYKEHUS HF 

Organization address
address: KIRKEVEIEN 166 TARNBYGGET
city: OSLO
postcode: 450
website: http://www.oslo-universitetssykehus.no

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙979˙485 €
 EC max contribution 3˙979˙485 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSLO UNIVERSITETSSYKEHUS HF NO (OSLO) coordinator 898˙118.00
2    "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""" EL (AGIA PARASKEVI) participant 719˙687.00
3    INSTITUTT FOR ENERGITEKNIKK NO (KJELLER) participant 559˙875.00
4    SYNTHETICA AS NO (OSLO) participant 446˙875.00
5    UNIVERSITAT POLITECNICA DE VALENCIA ES (VALENCIA) participant 384˙375.00
6    VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE CZ (PRAHA) participant 382˙500.00
7    UNIVERSITAT DE GIRONA ES (GIRONA) participant 336˙250.00
8    ACCELOPMENT AG CH (ZUERICH) participant 251˙803.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates. In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue. Current neutron-based therapies have sufficient penetration depth but suffer from lack of cancer specificity. In FRINGE we propose a genuinely new hybrid-technology. At its heart are chemical agents (photosensitisers - PS) which preferentially accumulate in the tumours especially in brain cancers where the blood brain barrier is compromised. The PSs designed for FRINGE will contain metal centres like Gadolinium (Gd), to enable interaction with incoming neutrons and facilitate the transfer of neutron energy into electron excitation of the PS, confirmed by concomitant fluorescence emission. Interaction with ambient oxygen will generate reactive oxygen species which will kill the tumour cells. The main scientific breakthrough of this project will be to establish experimental proof-of-principle of this novel neutron-activated therapy. FRINGE will combine the advantages of photomedical therapies (no mutagenic radiation) with the advantages of neutron-based therapies (large penetration depth). The externally-applied neutron beam can be energy-tuned to become therapeutic exactly at the depth of the tumour. Exploiting Gd as a contrast agent, FRINGE can also become a theranostic modality by use of magnetic resonance imaging. FRINGE has the potential of causing immunogenic cell death to cancers which could eliminate occult metastasis and act as a ‘cancer vaccine’. The highly interdisciplinary project team comprises world renowned experts from a unique combination of disciplines: Nuclear physicists, synthetic chemists, photochemists, photobiologists, medical physicists, quantum chemists and radio-oncologists will join forces to lay the foundations for a novel, curative cancer therapy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FRINGE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FRINGE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

QUEFORMAL (2019)

Quantum Engineering for Machine Learning

Read More  

SUPERGALAX (2020)

Highly sensitive detection of single microwave photons with coherent quantum network of superconducting qubits for searching galactic axions

Read More  

NanoBRIGHT (2019)

BRInGing nano-pHoTonics into the brain

Read More